2 results
Approved WMOPending
To evaluate the safety and efficacy of ravagalimab vs placebo for the treatment of primary Sjogren's syndrome (pSS) in subjects with moderately to severely active primary Sjogren's syndrome (pSS).
Approved WMOCompleted
The main objective of this study is to evaluate the safety, including stent migration rates, and efficacy of placement of the esophageal multisegmented fully covered SEMS with the OTW method in patients with non-operable malignant obstruction of the…